The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells
Open accessAbstract
The mechanism of antitumor effect of monoclonal antibodies (mAbs) is not fully understood. Here we show that coating myeloma cells with anti–syndecan-1 antibody promotes cross-presentation of cellular antigens by dendritic cells (DCs) to autologous T cells from healthy donors. The tumor cells treated with anti–syndecan-1 or isotype-matched control antibody were fed to HLA-mismatched monocyte-derived immature DCs. Tumor cell–loaded mature DCs induced a strong CD8+ T cell response that was specific for the cancer-testis (C-T) antigens expressed in the tumor. The CD8+ T cells killed peptide-pulsed targets, as well as myeloma tumor cells. Importantly, mAbs-coated tumor-loaded DCs were consistently superior to DCs loaded with peptides or dying cells for eliciting tumor-specific killer T cells. This enhanced cross-presentation was not due to enhanced tumor cell uptake or to DC maturation. When mixtures of NY-Eso-1-positive and -negative myeloma cells were captured by DCs, the anti–syndecan-1 antibody had to be on the NY-Eso-1-positive cells to elicit NY-Eso-1–specific response. Cross-presentation was inhibited by pretreatment of DCs with Fcγ receptor blocking antibodies. Targeting of mAb-coated tumors to DCs may contribute to the efficacy of tumor-reactive mAb and offers a new strategy for immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768 · cited 2×
“Fc receptors are required for both active and passive immunity to melanoma, (11) and the protective effect of therapeutic mAbs in some murine models (12).”
BackgroundRapid degradation of a large fraction of newly synthesized proteins by proteasomes
Schubert, U., Antón, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., & Bennink, J. R. (2000) · Nature · doi:10.1038/35008096 · Cited by 1,536
Albert, M. L., Pearce, S. F. A., Francisco, L. M., Sauter, B., Roy, P., Silverstein, R. L., & Bhardwaj, N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1359 · Cited by 1,234
Jonuleit, H., Kühn, U., Müller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J., & Enk, A. H. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271209 · Cited by 1,163
Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Théry, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.371 · Cited by 898
Cross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882
Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P., & Amigorena, S. (1999) · Nature Cell Biology · doi:10.1038/14058 · Cited by 552
Dhodapkar, M. V., Steinman, R. M., Sapp, M., Desai, H., Fossella, C., Krasovsky, J., Donahoe, S. M., Dunbar, P. R., Cerundolo, V., Nixon, D. F., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6909 · Cited by 468
Self-citationA plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1
Wijdenes, J., Vooijs, W. C., Clément, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R., Klein, B., & Dore, J. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1811.x · Cited by 340
Fc receptors are required in passive and active immunity to melanoma
Clynes, R., Takechi, Y., Moroi, Y., Houghton, A., & Ravetch, J. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.652 · Cited by 321
Berard, F., Blanco, P., Davoust, J., Neidhart-Berard, E.-M., Nouri-Shirazi, M., Taquet, N., Rimoldi, D., Cerottini, J. C., Banchereau, J., & Palucka, A. K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1535 · Cited by 284
Nouri-Shirazi, M., Banchereau, J., Bell, D., Burkeholder, S., Kraus, E. T., Davoust, J., & Palucka, K. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3797 · Cited by 242
Hoffmann, T. K., Meidenbauer, N., Dworacki, G., Kanaya, H., & Whiteside, T. L. (2000) · PubMed · Cited by 227
Manca, F., Fenoglio, D., Li Pira, G., Kunkl, A., & Celada, F. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.1.37 · Cited by 206
Immunity against cancer: lessons learned from melanoma
Houghton, A. N., Gold, J. S., & Blachere, N. E. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00195-3 · Cited by 190
Feuerstein, B., Berger, T. G., Maczek, C., Röder, C., Schreiner, D., Hirsch, U., Haendle, I., Leisgang, W., Glaser, A., Kuss, O., et al. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00269-6 · Cited by 159
Jenne, L., Arrighi, J.-F., Jonuleit, H., Saurat, J. ‐., & Hauser, C. (2000) · PubMed · Cited by 159
Vadhan‐Raj, S., Cordon‐Cardo, C., Carswell, E. A., Mintzer, D. M., Dantis, L., Duteau, C., Templeton, M. A., Oettgen, H. F., Old, L. J., & Houghton, A. N. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.10.1636 · Cited by 155
Herr, W., Ranieri, E., Olson, W. C., Zarour, H. M., Gesualdo, L., & Storkus, W. J. (2000) · Blood · doi:10.1182/blood.v96.5.1857 · Cited by 153
Fanger, N. A., Voigtlaender, D., Liu, C., Swink, S. L., Wardwell, K., Fisher, J., Graziano, R. F., Pfefferkorn, L. C., & Guyre, P. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.7.3090 · Cited by 147
Transport of macrophage Fc receptors and Fc receptor-bound ligands to lysosomes.
Ukkonen, P., Lewis, V., Marsh, M., Helenius, A., & Mellman, I. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.163.4.952 · Cited by 145
Scanlan, M. J., Altorki, N. K., Gure, A. O., Williamson, B., Jungbluth, A. A., Chen., Y., & Old, L. J. (2000) · Cancer Letters · doi:10.1016/s0304-3835(99)00385-7 · Cited by 140
Self-citationValmori, D., Gileadi, U., Servis, C., Dunbar, P. R., Cerottini, J., Romero, P. J., Cerundolo, V., & Lévy, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.895 · Cited by 128
Subklewe, M. S., Paludan, C., Tsang, M. L., Mahnke, K., Steinman, R. M., & Münz, C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.405 · Cited by 117
Fc receptors for IgG and antigen presentation on MHC class I and class II molecules
Amigorena, S., & Bonnerot, C. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0196 · Cited by 88
Monoclonal antibody therapies–a ‘constant’ threat to cancer
Houghton, A. N., & Scheinberg, D. A. (2000) · Nature Medicine · doi:10.1038/74621 · Cited by 87
Amigorena, S., Lankar, D., Briken, V., Gapin, L., Viguier, M., & Bonnerot, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.505 · Cited by 87
Exogenous antigen targeted to FcγRI on myeloid cells is presented in association with MHC class I
Wallace, P. K., Tsang, K. Y., Goldstein, J., Correale, P., Jarry, T. M., Schlom, J., Guyre, P. M., Ernstoff, M. S., & Fanger, M. W. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00351-3 · Cited by 48
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Therapeutic antibodies: successes, limitations and hopes for the future
Chames, P., Van Regenmortel, M., Weiss, E., & Baty, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00190.x · Cited by 1,382
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Metadata
- Authors
- Dhodapkar, K. M., Krasovsky, J., Williamson, B., & Dhodapkar, M. V.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-01-07
- Volume
- 195
- Issue
- 1
- Pages
- 125-133
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2124749346
- Cited by
- 349
- References
- 30
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.